NovoCure Ltd·4

Jan 3, 4:04 PM ET

Ben Arye Barak 4

4 · NovoCure Ltd · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2024-12-31
Ben Arye Barak
General Counsel
Transactions
  • Award

    Ordinary Shares

    2024-12-31$14.75/sh+669$9,866118,721 total
Footnotes (2)
  • [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. This transaction is also exempt under Rule 16b-3(c).
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 1, 2024.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    BARAK BEN ARYE SEC POWER OF ATTORNEY